About us
We have assembled an experienced team with strong scientific, clinical and commercial expertise.
InnoSIGN’s industry-leading platform will accelerate and expand the reach of life-saving therapies to patients everywhere.
Meet the team
Eric Lindquist
Chief Executive Officer
Anne van Brussel
Application Scientist
Laurent Holtzer
VP of Engineering
Marianna Polonsky
VP of Business Development, Commercial Strategy & Market Access
Dianne van Strijp
Product Application Specialist
Gwen Sülter
Business Operations Manager
Yvonne Wesseling-Rozendaal
Clinical Data ScientistBoard of Directors
Allan May
Chairman - Life Science Angels
Evan Castiglia
Thuja Capital
Mark Oldroyd
Independent Board Member
Eric Lindquist
CEO InnoSIGN
Paul Vernooij
Observer BOM